Classification of Non-Insulin Glucose Lowering Drugs.
J Pak Med Assoc · 2022
Last updated 2026-05-28| Journal | J Pak Med Assoc, 2022 |
|---|---|
| Citations | 5 |
| Relative citation ratio | 0.53 |
| NIH percentile | 31 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Abstract
The ever-changing scenario of diabetes care, especially pharmacotherapy, calls for a framework to help classify non-insulin glucose drugs. Such a taxonomic structure should be of contemporary relevance as well as futuristic in vision; scholarly in intent but easy to understand; and based on pathophysiologic principles while being useful for the clinician. We propose a rubric which lists four classes of non-insulin glucose lowering drugs; insulin secretagogues, insulin sensitizers, calorie restriction mimetics, and calorie restrictors. This classification serves the need of students and teachers as well as pharmacologists and clinicians alike.
Verbatim abstract via PubMed 35099465 ↗